Announcements

  • A human body showing various organs, on a background of biometric, biological and mathematical patterns

    This Collection of articles from across the Nature Reviews portfolio explores the transformative role of artificial intelligence in health care, from drug discovery and development, through to applications in the risk stratification, diagnosis, imaging, monitoring, prognostication, and pharmacological and surgical treatment of patients.

  • A diverse group of people

    This ongoing Series of articles highlights the importance of a more diverse, equitable and inclusive cardiovascular workforce in improving the quality of patient care and scientific research.

Advertisement

  • Targeting systemic metabolism through mild mitochondrial uncoupling with a controlled-release mitochondrial protonophore can reduce atherosclerosis in a mouse model of cardiometabolic syndrome, even when administered at late stages of disease progression.

    • Irene Fernández-Ruiz
    Research Highlight
  • Cardiac glycosides were the cornerstone of heart failure treatment for decades, but their use progressively declined after the introduction of modern prognostic medications. Two clinical trials now report that cardiac glycosides can reduce the risk of worsening heart failure events in patients with heart failure with reduced ejection fraction. These results do not mandate a paradigm shift but support a specific role for cardiac glycosides in selected patients.

    • Antonio Cannata
    • Theresa A. McDonagh
    Clinical Outlook
  • In this Journal Club article, Dar describes the first study to report the transcriptional coactivator YAP as a central regulator of cardiac regeneration in mice.

    • Ghulam Mehdi Dar
    Journal Club
  • As artificial intelligence (AI), multiomics and human organoids reshape cardiovascular research, calls to replace animal models are accelerating. We argue that understanding complex, multiorgan cardiovascular disease requires an integrated framework in which in vivo, in vitro and computational models each provide complementary biological insights.

    • Petra Kleinbongard
    • Bruno K. Podesser
    • Dunja Aksentijevic
    Comment

Anticoagulants

Anticoagulant drugs are used to prevent and treat thrombotic disorders in millions of patients worldwide. This Milestone plots the history of anticoagulant drugs, starting with the discovery and clinical trials of heparin and warfarin.
Milestone

Advertisement

Nature Careers

Science jobs

Advertisement